Differentiation of Recurrent Nasopharyngeal Carcinoma and Skull Base Osteoradionecrosis by Epstein-Barr Virus-Derived Latent Membrane Protein-1 Gene
- 1 April 2001
- journal article
- research article
- Published by Wiley in The Laryngoscope
- Vol. 111 (4) , 650-652
- https://doi.org/10.1097/00005537-200104000-00017
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Endoscopic Management of Skull Base OsteoradionecrosisThe Laryngoscope, 2000
- Systematic Management of Osteoradionecrosis in the Head and NeckThe Laryngoscope, 1999
- The role of brachytherapy in early-stage nasopharyngeal carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 1996
- Immunohistochemical expression of Epstein-Barr virus-encoded latent membrane protein (LMP-1) in paraffin sections of EBV-associated nasopharyngeal carcinoma in Spanish patientsOral Oncology, 1996
- Clonal Proliferations of Cells Infected with Epstein–Barr Virus in Preinvasive Lesions Related to Nasopharyngeal CarcinomaNew England Journal of Medicine, 1995
- Immunoglobulin A against viral capsid antigen of Epstein-Barr virus and indirect mirror examination of the nasopharynx in the detection of asymptomatic nasopharyngeal carcinomaCancer, 1992
- An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cellsCell, 1985
- Nasopharyngeal cancer: Study III. A review of 1206 patients treated with combined modalitiesInternational Journal of Radiation Oncology*Biology*Physics, 1985
- Elevated IgA in carcinoma of the nasopharynxCancer, 1975